Suppr超能文献

小鼠针对人偏肺病毒的原发性和回忆性H-2(d)限制性细胞毒性T淋巴细胞反应的定位与特征分析

Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus.

作者信息

Melendi Guillermina A, Zavala Fidel, Buchholz Ursula J, Boivin Guy, Collins Peter L, Kleeberger Steven R, Polack Fernando P

机构信息

Fundacion INFANT, Buenos Aires, Argentina.

出版信息

J Virol. 2007 Oct;81(20):11461-7. doi: 10.1128/JVI.02423-06. Epub 2007 Aug 1.

Abstract

Cytotoxic T lymphocytes (CTLs) are important for the control of virus replication during respiratory infections. For human metapneumovirus (hMPV), an H-2(d)-restricted CTL epitope in the M2-2 protein has been described. In this study, we screened the hMPV F, G, N, M, M2-1, and M2-2 proteins using three independent algorithms to predict H-2(d) CTL epitopes in BALB/c mice. A dominant epitope (GYIDDNQSI) in positions 81 to 89 of the antitermination factor M2-1 and a subdominant epitope (SPKAGLLSL) in N(307-315) were detected during the anti-hMPV CTL response. Passive transfer of CD8(+) T-cell lines against M2-1(81-89) and N(307-315) protected Rag1(-/-) mice against hMPV challenge. Interestingly, diversification of CTL targets to include multiple epitopes was observed after repetitive infections. A subdominant response against the previously described M2-2 epitope was detected after the third infection. An understanding of the CTL response against hMPV is important for developing preventive and therapeutic strategies against the virus.

摘要

细胞毒性T淋巴细胞(CTL)在呼吸道感染期间对控制病毒复制至关重要。对于人偏肺病毒(hMPV),已描述了M2-2蛋白中一个H-2(d)限制性CTL表位。在本研究中,我们使用三种独立算法筛选hMPV的F、G、N、M、M2-1和M2-2蛋白,以预测BALB/c小鼠中的H-2(d) CTL表位。在抗hMPV CTL反应期间,检测到抗终止因子M2-1第81至89位的一个显性表位(GYIDDNQSI)和N(307-315)中的一个隐性表位(SPKAGLLSL)。针对M2-1(81-89)和N(307-315)的CD8(+) T细胞系的被动转移保护Rag1(-/-)小鼠免受hMPV攻击。有趣的是,在重复感染后观察到CTL靶标多样化,包括多个表位。在第三次感染后检测到针对先前描述的M2-2表位的隐性反应。了解针对hMPV的CTL反应对于制定针对该病毒的预防和治疗策略很重要。

相似文献

引用本文的文献

1
Immunological insights into the re-emergence of human metapneumovirus.对人偏肺病毒再次出现的免疫学见解。
Curr Opin Immunol. 2025 Jun;94:102562. doi: 10.1016/j.coi.2025.102562. Epub 2025 May 12.
2
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus.研发一种新型多表位 mRNA 疫苗候选物以对抗 HMPV 病毒。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2293300. doi: 10.1080/21645515.2023.2293300. Epub 2024 Jan 3.
8
Prophylactic and therapeutic approaches for human metapneumovirus.人偏肺病毒的预防和治疗方法。
Virusdisease. 2018 Dec;29(4):434-444. doi: 10.1007/s13337-018-0498-5. Epub 2018 Oct 20.
9
The CD8 T Cell Response to Respiratory Virus Infections.CD8 T 细胞对呼吸道病毒感染的免疫反应
Front Immunol. 2018 Apr 9;9:678. doi: 10.3389/fimmu.2018.00678. eCollection 2018.

本文引用的文献

9
Human metapneumovirus as a major cause of human respiratory tract disease.人偏肺病毒是人类呼吸道疾病的主要病因。
Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S215-21. doi: 10.1097/01.inf.0000144668.81573.6d.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验